名臣健康(002919.SZ)上修業績預告 前三季淨利預增100%-130%
格隆匯10月13日丨名臣健康(002919.SZ)發佈2020年前三季度業績預告修正公告,修正後歸屬於上市公司股東的淨利潤4150.84萬元–4773.47萬元,同比增長100%-130%;基本每股收益0.34元-0.39元。
此次修正原因為:公司2020年日化業務發展勢頭向好,實現穩中有升,受疫情的影響,全民衞生健康意識增強,公司產品特別是洗滌類產品銷量增長;三季度同比增長超預期,帶來1-9月收入增長較多。
公司2020年8月,以自有資金收購海南華多網絡科技有限公司100%股權、杭州雷焰網絡科技有限公司100%股權,實現非同一控制下合併。自2020年9月起納入合併報表範圍,成為公司的全資子公司。9月份,公司全資子公司杭州雷焰網絡科技有限公司遊戲流水略超預期,影響公司遊戲板塊業績比原預計數有所增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.